BRIEF-Actelion gets Japanese nod for epoprostenol "ACT"
ZURICH Feb 18 (Reuters) - Actelion Ltd : * Actelion Pharmaceuticals Ltd : Actelion obtains marketing approval for
epoprostenol "ACT" in Japan
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video